Merck & Co. Inc. closed 41.19% below its 52-week high of $134.63, which the company reached on June 25th.

Semarion's SemaCyte® technology transforms adherent cell assays, enabling faster, automated workflows that enhance ...

Leaders at Merck & Co. Inc. are facing a new derivative shareholder lawsuit over allegations that they made misleading ...

Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in ...

A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs (shareholders) alleged that they bought MRK stock at artificially inflated ...

US pharmaceutical firm Merck & Co plans to build a £1 billion ... at the heart of the city’s life sciences “cluster”. The Financial Times reported that the company expects to employ ...

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

The issuer is solely responsible for the content of this announcement.

Evolution and innovation are critical to the field of life sciences, with each year bringing new challenges and breakthroughs. This holds especially true in the built environment — the labs ...

Apr. 8, 2025 — A new study maps how specific lactic acid bacteria can enhance both the flavor and nutritional quality of plant-based dairy alternatives. The findings may have wide-reaching ...

Allied Market Research published a report, titled, "Ferulic Acid Market by Source (Cereal Grains, Fruits and Vegetables, ...